All Relations between cannabis and Epilepsy

Publication Sentence Publish Date Extraction Date Species
Murali K Kolikonda, Kavitha Srinivasan, Manasa Enja, Vishwanath Sagi, Steven Lippman. Medical Marijuana for Epilepsy? Innovations in clinical neuroscience. vol 13. issue 3-4. 2016-06-29. PMID:27354925. medical marijuana for epilepsy? 2016-06-29 2023-08-13 Not clear
Murali K Kolikonda, Kavitha Srinivasan, Manasa Enja, Vishwanath Sagi, Steven Lippman. Medical Marijuana for Epilepsy? Innovations in clinical neuroscience. vol 13. issue 3-4. 2016-06-29. PMID:27354925. there is clinical evidence of success in diminishing seizure frequencies with cannabis derivatives, but also documentation about exacerbating epilepsy or of no discernible effect. 2016-06-29 2023-08-13 Not clear
Natalia Brzozowska, Kong M Li, Xiao Suo Wang, Jessica Booth, Jordyn Stuart, Iain S McGregor, Jonathon C Arnol. ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice. PeerJ. vol 4. 2016-06-03. PMID:27257556. cannabidiol (cbd) is currently being investigated as a novel therapeutic for the treatment of cns disorders like schizophrenia and epilepsy. 2016-06-03 2023-08-13 mouse
Kamil Detyniecki, Lawrence Hirsc. Marijuana Use in Epilepsy: The Myth and the Reality. Current neurology and neuroscience reports. vol 15. issue 10. 2016-05-09. PMID:26299273. this review attempts to answer the most important questions a clinician may have regarding the use of marijuana in epilepsy. 2016-05-09 2023-08-13 human
Kamil Detyniecki, Lawrence Hirsc. Marijuana Use in Epilepsy: The Myth and the Reality. Current neurology and neuroscience reports. vol 15. issue 10. 2016-05-09. PMID:26299273. lastly, we attempt to reconcile the controversy regarding physicians' and patients' opinions about whether the available evidence is sufficient to recommend the use of marijuana to treat epilepsy. 2016-05-09 2023-08-13 human
Marta Rubio, Sara Valdeolivas, Fabiana Piscitelli, Roberta Verde, Valentina Satta, Eva Barroso, Marisol Montolio, Luis Miguel Aras, Vincenzo Di Marzo, Onintza Sagredo, Javier Fernández-Rui. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome. Pharmacology research & perspectives. vol 4. issue 2. 2016-04-12. PMID:27069631. cannabidiol (cbd) reduces seizures in childhood epilepsy syndromes including dravet syndrome (ds). 2016-04-12 2023-08-13 Not clear
Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Michael Berk, Olivia Dean, Charles Spielholz, Richard Fry. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neuroscience and biobehavioral reviews. vol 55. 2016-04-04. PMID:25957927. in this systematic review we find favorable evidence for the use of nac in several psychiatric and neurological disorders, particularly autism, alzheimer's disease, cocaine and cannabis addiction, bipolar disorder, depression, trichotillomania, nail biting, skin picking, obsessive-compulsive disorder, schizophrenia, drug-induced neuropathy and progressive myoclonic epilepsy. 2016-04-04 2023-08-13 Not clear
Michael J Riede. Is the medical use of cannabis a therapeutic option for children? Paediatrics & child health. vol 21. issue 1. 2016-03-04. PMID:26941559. current considerations regarding cannabis use for medical purposes in children have been stimulated by recent case reports describing its beneficial effect with refractory epilepsy. 2016-03-04 2023-08-13 Not clear
Francis M Fillou. Cannabinoids for pediatric epilepsy? Up in smoke or real science? Translational pediatrics. vol 4. issue 4. 2016-02-02. PMID:26835389. public interest in the use of "medical marijuana" for the treatment of childhood epilepsy has burgeoned in the last few years. 2016-02-02 2023-08-13 Not clear
Francis M Fillou. Cannabinoids for pediatric epilepsy? Up in smoke or real science? Translational pediatrics. vol 4. issue 4. 2016-02-02. PMID:26835389. the evidence-base supporting or not the use of cannabis products for the treatment of neurological disease and specifically epilepsy is explored. 2016-02-02 2023-08-13 Not clear
Shaun A Hussain, Raymond Zhou, Catherine Jacobson, Julius Weng, Emily Cheng, Johnson Lay, Phoebe Hung, Jason T Lerner, Raman Sanka. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy & behavior : E&B. vol 47. 2016-01-11. PMID:25935511. perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and lennox-gastaut syndrome. 2016-01-11 2023-08-13 Not clear
Shaun A Hussain, Raymond Zhou, Catherine Jacobson, Julius Weng, Emily Cheng, Johnson Lay, Phoebe Hung, Jason T Lerner, Raman Sanka. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy & behavior : E&B. vol 47. 2016-01-11. PMID:25935511. we conducted a brief online survey of parents who administered cbd-enriched cannabis preparations for the treatment of their children's epilepsy. 2016-01-11 2023-08-13 Not clear
Dimah Saade, Charuta Josh. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. Pediatric neurology. vol 52. issue 5. 2016-01-05. PMID:25882081. recent widespread interest in the nonpsychoactive component of the cannabis plant, cannabidiol, as a potential treatment for refractory devastating epilepsies has led to individual trials initiated by families or physicians in states that have legalized medical marijuana with anecdotal success. 2016-01-05 2023-08-13 Not clear
István Katon. Cannabis and Endocannabinoid Signaling in Epilepsy. Handbook of experimental pharmacology. vol 231. 2015-12-16. PMID:26408165. cannabis and endocannabinoid signaling in epilepsy. 2015-12-16 2023-08-13 Not clear
István Katon. Cannabis and Endocannabinoid Signaling in Epilepsy. Handbook of experimental pharmacology. vol 231. 2015-12-16. PMID:26408165. recent changes in legal restrictions and new well-documented cases reporting remarkably strong beneficial effects have triggered an upsurge in exploiting medical marijuana in patients with refractory epilepsy. 2015-12-16 2023-08-13 Not clear
Steven C Schachte. Translating Nature to Nurture: Back to the Future for "New" Epilepsy Therapies. Epilepsy currents. vol 15. issue 6. 2015-12-04. PMID:26633945. an emerging strategy for finding new epilepsy therapies is focused on botanicals (as illustrated by recent attention to medical marijuana), given their centuries-old traditions of use in treatment of convulsive seizures, contemporary anecdotal reports of efficacy in persons with epilepsy, and identification of underlying mechanisms of action that are relevant to epilepsy. 2015-12-04 2023-08-13 Not clear
Craig A Press, Kelly G Knupp, Kevin E Chapma. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & behavior : E&B. vol 45. 2015-11-25. PMID:25845492. parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. 2015-11-25 2023-08-13 Not clear
Craig A Press, Kelly G Knupp, Kevin E Chapma. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & behavior : E&B. vol 45. 2015-11-25. PMID:25845492. oral cannabis extracts (oces) have been used in the treatment of epilepsy; however, no studies demonstrate clear efficacy. 2015-11-25 2023-08-13 Not clear
Alexandra L Geffrey, Sarah F Pollack, Patricia L Bruno, Elizabeth A Thiel. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. vol 56. issue 8. 2015-10-13. PMID:26114620. drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. 2015-10-13 2023-08-13 human
Alexandra L Geffrey, Sarah F Pollack, Patricia L Bruno, Elizabeth A Thiel. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. vol 56. issue 8. 2015-10-13. PMID:26114620. under an expanded access investigational new drug (ind) trial, cannabidiol (cbd) is being studied as a possible adjuvant treatment of refractory epilepsy in children. 2015-10-13 2023-08-13 human